Aeon Biopharma inc (AEON) — Comparison of Productivity to Peers

Aeon Biopharma inc 's Productivity vs Peers Comparison

Table 1: Market Cap, Revenue per Employee, Income per Employee for the 12 Months period ended in Q3 2025

What this table shows: Productivity metrics illustrate how effectively a company converts workforce and capital into value. Higher Revenue per Employee and Net Income per Employee generally reflect stronger operating efficiency and business scalability. First row shows Company's Productivity, followed by it's corporate peers. Click any company name in the table to view its complete financial analysis and comparison.

Aeon Biopharma inc 's Financial Strength vs Peers Comparison

Table 2: Quick Ratio, Working Capital, Debt/Equity, Asset Turnover

What this table shows: Financial Strength ratios measure short-term liquidity (Quick Ratio, Working Capital), leverage (Debt/Equity), and operational utilization (Asset Turnover). These indicators highlight how well management allocates resources and maintains financial stability.

Aeon Biopharma inc 's Underlying Financial Totals (Revenue, Income, Employees) vs Peers Comparison

Table 3: Revenue (TTM), Net Income (TTM), Net Margin, Employees, ending Q3 2025

Methodology & Data Source: Market Capitalization is computed from the latest available share price (delayed up to 15 minutes, depending on exchange rules) multiplied by the company’s diluted share count as reported in its filings. Revenue and Net Income figures used to calculate Revenue per Employee and Net Income per Employee are sourced directly from quarterly and annual financial statements submitted to the U.S. Securities and Exchange Commission (SEC). Employee counts are taken from the most recent Form 10-K or 10-Q disclosure and may be updated by companies in subsequent SEC submissions. All fundamentals are processed through CSIMarket.com’s XBRL normalization pipeline, which standardizes reported values across all issuers and periods.

Data lineage: SEC Filings → XBRL Extraction → CSIMarket Normalization → Productivity Metrics.

This table is one of the productivity comparisons available for Aeon Biopharma inc . Across CSIMarket, we provide nine related comparison tables showing how Aeon Biopharma inc performs against its Peers, including additional breakdowns visible through our main navigation bar under:
Stocks → Peers.

This page compares Aeon Biopharma inc to its Peers based on Productivity (Market Cap, Revenue per Employee, and Net Income per Employee).

• For a deeper productivity comparison against its industry peers, visit
Aeon Biopharma inc Productivity vs. Industry

• To review historical productivity trends for this company, including long-term changes in Revenue per Employee and Net Income per Employee, visit
Aeon Biopharma inc Productivity History

Page last updated: November 29, 2025

CSIMarket data powering this analysis is available across multiple delivery channels:
• Data Downloads (CSV / Excel)
• API & Programmatic Data Access
• Enterprise Data Licensing
• AI Training & Model Development License
• Marketplace Distribution Options

All CSIMarket datasets are designed for analytical workflows, financial modeling, academic research, and AI/ML applications requiring normalized, reliable, and longitudinal financial time series.

To download the tables, please subscribe.